TherapeuticsMD
TXMD
TXMD
134 hedge funds and large institutions have $867M invested in TherapeuticsMD in 2017 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 40 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.01% less ownership
Funds ownership: 1.53% → 1.52% (-0.01%)
16% less call options, than puts
Call options by funds: $1.89M | Put options by funds: $2.27M
Holders
134
Holding in Top 10
–
Calls
$1.89M
Puts
$2.27M
Top Buyers
| 1 | +$32.5M | |
| 2 | +$15.8M | |
| 3 | +$14.9M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.83M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.59M |
Top Sellers
| 1 | -$23.2M | |
| 2 | -$3.95M | |
| 3 | -$3.44M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$2.98M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.56M |